Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 6984720 Human CTLA-4 antibodies

Patent 6984720 was granted and assigned to Medarex (company) on January, 2006 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Current Assignee

Medarex (company)

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Alan J. Korman0

Edward L. Halk0

Nils Lonberg0

Tibor P. Keler0

Yashwant M. Deo0

Date of Patent

January 10, 2006

0

Patent Application Number

096446680

Date Filed

August 24, 2000

0

Patent Citations Received

US Patent 12128018 Combination of a selective histone deacetylase 3 (HDAC3) inhibitor and an immunotherapy agent for the treatment of cancer

0

US Patent 11988671 Assays for detecting SARS-CoV-2

0

US Patent 11993651 Anti-lag-3 antibodies and methods of use thereof

0

US Patent 12006347 Superagonists and antagonists of interleukin-2

0

US Patent 12084518 Trispecific binding proteins and methods of use

0

US Patent 12090147 Combination therapy with 2-(4-chlorophenyl)-N-((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-5-yl)methyl)-2,2-difluoroacetamide

0

US Patent 12090183 Methods of treating solid or lymphatic tumors by combination therapy

0

US Patent 12103922 Macrocyclic complexes of alpha-emitting radionuclides and their use in targeted radiotherapy of cancer

0

...

Patent Primary Examiner

0

Patent abstract

The present invention provides human sequence antibodies against CTLA-4 and methods of treating human diseases, infections and other conditions using these antibodies.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 6984720 Human CTLA-4 antibodies

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool